aTyr Pharma Announces Third Quarter 2020 Results and Provides Corporate Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/13/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
aTyr Pharma (LIFE) Tops Q3 EPS by 6c
November 12, 2020 4:38 PM ESTaTyr Pharma (NASDAQ: LIFE) reported Q3 EPS of ($0.68), $0.06 better than the analyst estimate of ($0.74). Revenue for the quarter came in at $148 thousand versus the consensus estimate of $100 thousand.
Throughout the third quarter, we remained focused on our clinical program for our lead therapeutic candidate, ATYR1923. We now... More
